Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial--Intergroup Collaborative Study (Q44211312)
Jump to navigation
Jump to search
scientific article published on 17 October 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial--Intergroup Collaborative Study |
scientific article published on 17 October 2002 |
Statements
1 reference
Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial--Intergroup Collaborative Study (English)
1 reference
Van Oers MH
1 reference
Hagenbeek A
1 reference
Van Glabbeke M
1 reference
Teodorovic I
1 reference
17 October 2002
1 reference
1 reference
81
1 reference
10
1 reference
553-557
1 reference
Identifiers
1 reference
1 reference